← Leaderboards
Duncan John Wardrop
Georgetown University
$3,076,392
Attributed
$5,388,051
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $659.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,388,051 · 4
By mechanism
R01$5,388,051 · 4
Top collaborators
- Alejandro V Villagra6 shared
- Cyril Barinka5 shared
- Barbara J. Caldarone1 shared
- Bryan L Roth1 shared
Most similar at Georgetown University
Same institution · by research overlap
- Stefano Vicini$8,803,601
- Kristen Kathleen Foster$1,008,214
Others in their field
Top investigators on “Cytotoxicity”
- David Heimbrook · Leidos Biomedical Research, Inc.$60,494,681
- Philip J Disaia · University Of California Irvine$58,213,103
- Kent J. Weinhold · Duke University$45,381,151
- Brenda J. Weigel · University Of Minnesota$36,792,183
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$34,242,475
- Douglas F Nixon · J. David Gladstone Institutes$30,748,895
Research focus
CytotoxicityInnovationDesignPre-ClinicalMetabolicCharacteristicsIn VitroInterestMolecular TargetReceptorPharmaceutical ChemistryIn VivoGeneticAnti-Inflammatory AgentsCd8b1 GeneCytokineCellsCardiacCtla4 GeneCytotoxicAttentionBlocking AntibodiesCancer TherapyCancer Cell
Grant awards (15)
Development of selective HDAC6 inhibitors to improve cancer immunotherapy$573,024
R01 · FY2025 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy$567,683
R01 · FY2024 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy$605,710
R01 · FY2023 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy$514,297
R01 · FY2022 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy$104,326
R01 · FY2022 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy$586,358
R01 · FY2021 · CA
Optimizing Lead 5-HT2c Ligands for Use in the Treatment of Schizophrenia$659,346
R01 · FY2016 · MH · contact PI
Synthesis through N-Acylnitrenium Ion Cyclization$255,395
R01 · FY2006 · GM · contact PI
Synthesis through N-Acylnitrenium Ion Cyclization$261,868
R01 · FY2005 · GM
Synthesis through N-Acylnitrenium Ion Cyclization$260,421
R01 · FY2004 · GM
Synthesis through N-Acylnitrenium Ion Cyclization$260,781
R01 · FY2003 · GM
NATURAL PRODUCT SYNTHESIS THROUGH TEMPLATE DIRECTED C-H$192,861
R01 · FY2003 · GM
NATURAL PRODUCT SYNTHESIS THROUGH TEMPLATE DIRECTED C-H$187,320
R01 · FY2002 · GM
NATURAL PRODUCT SYNTHESIS THROUGH TEMPLATE DIRECTED C-H$181,942
R01 · FY2001 · GM
NATURAL PRODUCT SYNTHESIS THROUGH TEMPLATE DIRECTED C-H$176,719
R01 · FY2000 · GM